WebXue W, Ma J, Yu X, Ruan Z, Sun Y, Wu T, Zhang X and Wu L (2024) Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis, BMC Cardiovascular Disorders, 10.1186/s12872-022-02923-z, 22:1 WebRestenosis means the recurrence of a treated coronary artery stenosis over time. Restenosis usually manifests itself clinically over the 1- to 6-month period following PCI. …
Sirolimus-Eluting Stents vs Vascular Brachytherapy for In-Stent ...
WebNov 20, 2024 · However, the incidence and possible influencing factors associated with binary restenosis have not yet been adequately assessed. Methods: ... At the 9-month coronary angiographic follow-up, patients were divided into restenosis and non-restenosis groups, and demographic data, lesion features, and laboratory tests were retrospectively … WebMar 5, 2015 · Moreover, binary restenosis (primary endpoint), percent diameter stenosis, and TLR were similar between DCB- and DES-treated patients, but MLD and late luminal loss were greater in the DES group (table 1). Propensity-score matching also confirmed similarity between the treatments for 12-month clinical results. DCB Better for Complex … sic rhein-main gmbh offenbach
Restenosis - Wikipedia
WebDespite the marked reduction in restenosis rates with the use of DES as compared to the use of POBA and BMS, clinically driven TLR remains common. These events which … WebNov 20, 2024 · Background: Drug-coated balloon (DCB) is a novel and effective device for coronary artery disease patients with in-stent restenosis (ISR). However, the … WebBinary restenosis was defined as a 50% lumen diameter reduction as shown by conventional or digital subtraction angiography during the follow-up or a >50% hemodynamic stenosis determined by duplex ultrasound based on a ≥2.5 peak systolic velocity ratio. The secondary endpoints included technical success, stent fracture, major … the pig dublin